Celltrion Reveals Data As It Rolls Out Higher-Strength Adalimumab

Presents One-Year Data From Phase III Trial For Yuflyma Rival To Humira

 
• By David Wallace
  
Spain Europe Map Scratch Off
Spain is one of the initial launch markets for Yuflyma • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products